معرفی
Yaser Atlasi is a Senior Lecturer at Queen's University Belfast's School of Medicine, Dentistry and Biomedical Sciences, affiliated with the Patrick G Johnston Centre for Cancer Research. His research focuses on epigenetic regulation in health and disease, particularly using embryonic stem cells and organoids to explore parallels between embryonic, adult, and cancer stem cells. He employs advanced genomic and proteomic techniques combined with computational biology to address societal health challenges.
Key research interests include epigenetic mechanisms, stem cell differentiation, cancer biology, and drug resistance. He leads projects funded by Queen’s Catalyst and other grants, investigating topics like USP7-PRC1.6 regulation in cancer, enhancer SNPs in breast cancer, and drug-resistant lymphomas. His lab (www.atlasilab.com) emphasizes translational research, bridging basic science and clinical applications.
Atlasi has received awards including the EMBO Travel Award (2023), Queen’s CATALYST award (2021), and Young Investigator Award (2016). He actively participates in academic activities, including invited talks at the Crick Institute and joint BSDB/Genetics Society conferences. His research spans collaborations in the UK and internationally, addressing stem cell plasticity, epigenetic pathways, and therapeutic targets in cancer.
Atlasi supervises doctoral students and contributes to editorial activities, peer review, and academic outreach. His work intersects multiple disciplines, including computational biology, drug development, and regenerative medicine, reflecting his commitment to interdisciplinary approaches in science.
